Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,434,593
  • Shares Outstanding, K 42,121
  • Annual Sales, $ 421,030 K
  • Annual Income, $ -11,020 K
  • 60-Month Beta 1.31
  • Price/Sales 5.75
  • Price/Cash Flow 33.31
  • Price/Book 6.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.35
  • Number of Estimates 7
  • High Estimate -0.08
  • Low Estimate -0.63
  • Prior Year 0.23
  • Growth Rate Est. (year over year) -252.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.96 +41.11%
on 06/15/20
58.45 -1.11%
on 07/10/20
+11.03 (+23.58%)
since 06/10/20
3-Month
33.47 +72.69%
on 04/16/20
58.45 -1.11%
on 07/10/20
+22.11 (+61.95%)
since 04/09/20
52-Week
27.46 +110.49%
on 03/23/20
58.45 -1.11%
on 07/10/20
+14.66 (+33.98%)
since 07/10/19

Most Recent Stories

More News
Top Ranked Momentum Stocks to Buy for July 10th

Top Ranked Momentum Stocks to Buy for July 10th

UMRX : 3.32 (+10.30%)
PCRX : 57.80 (+0.49%)
NLS : 10.66 (+2.60%)
BSIG : 12.74 (+3.75%)
PCRX Crosses Above Average Analyst Target

In recent trading, shares of Pacira BioSciences Inc have crossed above the average analyst 12-month target price of $56.57, changing hands for $57.52/share. When a stock reaches the target an analyst...

PCRX : 57.80 (+0.49%)
Uptrend Call Working As Pacira Pharmaceu Stock Rises 63.6% (PCRX)

SmarTrend identified an Uptrend for Pacira Pharmaceu (NASDAQ:PCRX) on April 9th, 2020 at $34.69. In approximately 3 months, Pacira Pharmaceu has returned 63.64% as of today's recent price of $56.76.

PCRX : 57.80 (+0.49%)
The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio

The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio

TBIO : 16.99 (-1.05%)
PCRX : 57.80 (+0.49%)
ATNM : 0.3690 (+2.50%)
ALPN : 9.80 (+3.59%)
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025

Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $350.0 million aggregate principal amount of convertible senior notes due 2025 (the "notes") in a private placement to qualified institutional...

PCRX : 57.80 (+0.49%)
Look for Shares of Pacira Pharmaceu to Potentially Pullback after Yesterday's 2.29% Rise

Pacira Pharmaceu (NASDAQ:PCRX) traded in a range yesterday that spanned from a low of $52.03 to a high of $56.23. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high...

PCRX : 57.80 (+0.49%)
Pacira (PCRX) Provides Preliminary Results for Second Quarter

Pacira (PCRX) reports preliminary results for the second quarter of 2020. The company's product sales are hurt by the COVID-19 pandemic. The stock fell in pre-market trading.

BLRX : 1.8100 (+1.69%)
PCRX : 57.80 (+0.49%)
ATXI : 9.76 (+0.10%)
AMRX : 4.65 (+6.65%)
4 Small Drug Stocks Worth Betting on Amid Coronavirus Woes

Here we discuss four small stocks from the drug sector, which hold potential for a good run amid the coronavirus crisis.

TBIO : 16.99 (-1.05%)
PCRX : 57.80 (+0.49%)
ATNM : 0.3690 (+2.50%)
ALPN : 9.80 (+3.59%)
Pacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior Notes

Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer, subject to market and other conditions, $300.0 million aggregate principal amount of convertible senior notes due 2025...

PCRX : 57.80 (+0.49%)
Pacira BioSciences Reports Preliminary Total Revenue of $75.5 Million for Second Quarter of 2020

Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today reported preliminary unaudited net revenue of $75.5 million for the second quarter of...

PCRX : 57.80 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade PCRX with:

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

2nd Resistance Point 59.29
1st Resistance Point 58.55
Last Price 57.80
1st Support Level 56.96
2nd Support Level 56.11

See More

52-Week High 58.45
Last Price 57.80
Fibonacci 61.8% 46.61
Fibonacci 50% 42.96
Fibonacci 38.2% 39.30
52-Week Low 27.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar